Our Process

• Minimal manipulation
• Native state

• Never frozen
• No micronization
• No harsh chemicals
• No lyophilization

• Minimal degradation of tissue structure
• Minimal denaturation of proteins

Strict adherence to FDA CFR Title 21,  Part 1271, Section 361
HCT/P (Human Cells, Tissues, and Cellular and  Tissue-Based Products) regulations
Patent application submitted May 9th, 2018